INTERNATIONAL PATENT: OTSUKA PHARMACEUTICAL CO., LTD. FILES APPLICATION FOR "PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY"

GENEVA, May 27 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machiChiyoda-ku, Tokyo 1018535) filed a patent application (PCT/IB2024/061378) for "PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY" on Nov 15, 2024. With publication no. WO/2025/104679, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHAKYA, Sagar (4420 Rosewood Drive, Suite 200,Pleasanton, California 94588), JOHNSON, Matt (4420 Rosewood Drive, Suite 200,Pleasanton, California 94588...